These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 14607947)

  • 1. Differential induction of TGF-beta regulates proinflammatory cytokine production and determines the outcome of lethal and nonlethal Plasmodium yoelii infections.
    Omer FM; de Souza JB; Riley EM
    J Immunol; 2003 Nov; 171(10):5430-6. PubMed ID: 14607947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii.
    Kobayashi F; Morii T; Matsui T; Fujino T; Watanabe Y; Weidanz WP; Tsuji M
    Parasitol Res; 1996; 82(5):385-91. PubMed ID: 8738275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential role of T regulatory and Th17 in Swiss mice infected with Plasmodium berghei ANKA and Plasmodium yoelii.
    Keswani T; Bhattacharyya A
    Exp Parasitol; 2014 Jun; 141():82-92. PubMed ID: 24675415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of lethal Plasmodium yoelii malaria following protective immunization requires antibody-, IL-4-, and IFN-gamma-dependent responses induced by vaccination and/or challenge infection.
    Petritus PM; Burns JM
    J Immunol; 2008 Jan; 180(1):444-53. PubMed ID: 18097046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage-mediated but gamma interferon-independent innate immune responses control the primary wave of Plasmodium yoelii parasitemia.
    Couper KN; Blount DG; Hafalla JC; van Rooijen N; de Souza JB; Riley EM
    Infect Immun; 2007 Dec; 75(12):5806-18. PubMed ID: 17923512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection.
    Qi Z; Han X; Zhang Y; Wang J; Cao YM
    Tohoku J Exp Med; 2013 Feb; 229(2):87-96. PubMed ID: 23303295
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early gamma interferon responses in lethal and nonlethal murine blood-stage malaria.
    De Souza JB; Williamson KH; Otani T; Playfair JH
    Infect Immun; 1997 May; 65(5):1593-8. PubMed ID: 9125535
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
    Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
    Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cutting edge: the acquisition of TLR tolerance during malaria infection impacts T cell activation.
    Perry JA; Olver CS; Burnett RC; Avery AC
    J Immunol; 2005 May; 174(10):5921-5. PubMed ID: 15879082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathology of Plasmodium chabaudi chabaudi infection and mortality in interleukin-10-deficient mice are ameliorated by anti-tumor necrosis factor alpha and exacerbated by anti-transforming growth factor beta antibodies.
    Li C; Sanni LA; Omer F; Riley E; Langhorne J
    Infect Immun; 2003 Sep; 71(9):4850-6. PubMed ID: 12933825
    [TBL] [Abstract][Full Text] [Related]  

  • 11. gamma delta T-cells may interfere with a productive immune response in Plasmodium yoelii infections.
    Kopacz J; Kumar N
    Int J Parasitol; 1999 May; 29(5):737-42. PubMed ID: 10404269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of IL-18 in blood-stage immunity against murine malaria Plasmodium yoelii 265 and Plasmodium berghei ANKA.
    Singh RP; Kashiwamura S; Rao P; Okamura H; Mukherjee A; Chauhan VS
    J Immunol; 2002 May; 168(9):4674-81. PubMed ID: 11971017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elevated levels of the Plasmodium yoelii homologue of macrophage migration inhibitory factor attenuate blood-stage malaria.
    Thorat S; Daly TM; Bergman LW; Burns JM
    Infect Immun; 2010 Dec; 78(12):5151-62. PubMed ID: 20837716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Outcome of primary lethal and nonlethal Plasmodium yoelii malaria infection in BALB/c and IFN-γ receptor-deficient mice following chloroquine treatment.
    Ishih A; Kawakami C; Todoroki A; Hirai H; Ohori K; Kobayashi F
    Parasitol Res; 2013 Feb; 112(2):773-80. PubMed ID: 23180129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta production is inversely correlated with severity of murine malaria infection.
    Omer FM; Riley EM
    J Exp Med; 1998 Jul; 188(1):39-48. PubMed ID: 9653082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dendritic cells from malaria-infected mice are fully functional APC.
    Perry JA; Rush A; Wilson RJ; Olver CS; Avery AC
    J Immunol; 2004 Jan; 172(1):475-82. PubMed ID: 14688357
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of in vivo administration of anti-IL-10 or anti-IFN-gamma monoclonal antibody on the host defense mechanism against Plasmodium yoelii yoelii infection.
    Kobayashi F; Ishida H; Matsui T; Tsuji M
    J Vet Med Sci; 2000 Jun; 62(6):583-7. PubMed ID: 10907683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasmodium yoelii in mice: differential induction of cytokine gene expression during hyporesponsiveness induction and restimulation.
    Lucas B; Smith K; Haque A
    Cell Immunol; 1995 Jan; 160(1):79-90. PubMed ID: 7842488
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Murine gamma delta T lymphocytes elicited during Plasmodium yoelii infection respond to Plasmodium heat shock proteins.
    Kopacz J; Kumar N
    Infect Immun; 1999 Jan; 67(1):57-63. PubMed ID: 9864196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver CD4-CD8- NK1.1+ TCR alpha beta intermediate cells increase during experimental malaria infection and are able to exhibit inhibitory activity against the parasite liver stage in vitro.
    Pied S; Roland J; Louise A; Voegtle D; Soulard V; Mazier D; Cazenave PA
    J Immunol; 2000 Feb; 164(3):1463-9. PubMed ID: 10640763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.